Table 1.
Summary of the representative preclinical mouse models of human atopic dermatitis
Category | advantages /limitations | Examples | Characteristics | References |
---|---|---|---|---|
Inbred models | ||||
Pros: resembles natural course of human AD; enhanced percutaneous sensitization to haptens and allergens | Flaky tail (ma/ma, Flgft/ft) |
|
(Fallon et al., 2009, Sasaki et al., 2013, Saunders et al., 2013) | |
Cons: lack of genetic information in some strains; variable induction protocols when combined with hapten- or allergen-challenges; some models do not spontaneously develop dermatitis under SPF conditions | NC/Nga |
|
(Kohara et al., 2001, Matsuda et al., 1997) | |
Genetically-engineered models | ||||
Pros: useful in elucidating gene-specific functions in vivo; powerful when crossed with other strains |
Overexpression IL-4 (K14-IL4 Tg) IL-13 (K5-tTA-IL13 Tg) |
|
(Chan et al., 2006, Zheng et al., 2009) | |
Cons: time-consuming and expensive to generate; undesirable effect by unexpected gene expression or alteration (i.e. variable penetrance, inefficiency of Cre) | IL-31 (EF1α-IL31 or Eμ-Lck-IL31 Tg) |
|
(Dillon et al., 2004) | |
TSLP (K5-rtTA-TSLP Tg) IL-18 (K14-IL18 Tg) IL-33 (K14-IL33 Tg) |
|
(Imai et al., 2013, Konishi et al., 2002, Yoo et al., 2005) | ||
JAK1 (Jak1spade/spade) |
|
(Yasuda et al., 2016) | ||
Ablation ADAM17 (Adam17fl/fl Sox9Cre) |
|
(Kobayashi et al., 2015) | ||
CARMA-1 (unmodulated) |
|
(Jun et al., 2003) | ||
Induced models by exogenous agents | ||||
Pros: time-controlled induction; applicable to various mouse strains Cons: non-standardized products for some allergens; variable protocols (doses and durations); labor-intensive (daily applications) |
Hapten- induced (ex. oxazolone, TNCB) Allergen-induced (ex. ovalbumin, house dust mite) |
|
(Kitagaki et al., 1995, Kitagaki et al., 1997, Matsuoka et al., 2003, Spergel et al., 1998, Wang et al., 2007) | |
MC903 (calcipotriol)- induced |
|
(Kim et al., 2013, Li et al., 2006, Myles et al., 2016, Naidoo et al., 2018, Oetjen et al., 2017) |